Potential of ethosomes for enhanced transdermal drug delivery in skin diseases

Document Type : Review Paper

Authors

Department of Pharmaceutics, Delhi Institute of Pharmaceutical Sciences and Research, Delhi Pharmaceutical Sciences and Research University (DPSRU) Pushp Vihar Sector III, MB Road, New Delhi- 110017 (INDIA) New Delhi

Abstract

Ethosomes are novel ethanolic phospholipid vesicles which are significantly used for the transdermal drug delivery. Ethanol is an efficient permeation enhancer which is used in ethosomes about 20-45%. These are non-invasive in nature and have emerged as an area of active research interest because they significantly lead to enhanced skin penetration, improvement in drug delivery, increased drug entrapment efficiency it can deliver both hydrophilic and lipophilic drugs efficiently. Increased patient compliance etc. The drug penetrates the skin surface and gets absorbed by two phases i.e., the ethanol effect and ethosomes effect. Ethosomes are predominantly being used over liposomes because of their greater penetration rate which is attributed to the high concentration of ethanol. Hence it is an active area of research. The primary aim of the review is to provide a comprehensive account on the methods of preparation, properties, characterization, advantages and applications of ethosomes in the management of several skin diseases.

Keywords

References

1. Godin B & Touitou E. Ethosomes: New Prospects in Transdermal Delivery. Crit Rev Ther Drug Carrier Syst CRIT REV Ther Drug. 2003;20(1):63–102.
2.    Schaefer H, Redelmeier TE. Skin Barrier-Principles of Percutaneous Absorption. Basel: Karger AG, 1996.
3.     Bendas ER, Tadros MI. Enhanced transdermal delivery of sulbutamol sulfate via ethosomes. AAPS Pharm Sci Tech. 2007;8:1–7
4.    Barry WB. Dermatological Formulations: Percutaneous Absorption. New York, Basel: Marcel Dekker, 1983.
5.    Touitou E, Dayan N, Bergelson L, Godin B, Eliaz M. Ethosomes-novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release 2000;65:403–418.
6.    Touitou E. Compositions for applying active substances to or through the skin. US patent 5,540,934, 1996.
7.    Touitou E. Composition for applying active substances to or through the skin. US patent 5,716,638, 1998. 
8.    Touitou E, Alkabes M, Dayan N, Eliaz M. Ethosomes: the novel vesicular carriers for enhanced skin delivery. Pharm Res 1997;14:S 305. 
9.    Touitou E, Godin B, Weiss C. Enhanced delivery of drugs into and across the skin by ethosomal carriers. Drug Dev Res 2000;50:406–415.
10.    Akiladevi D, Sachinandan B. Ethosomes- A Non-invasive approach for Transdermal Drug Delivery. Int J Curr Pharm Res. 2010; 2(4): 15-26.
11.    Jain S, Tiwary AK, Sapra B, Jain NK. Formulation and evaluation of ethosomes for transdermal delivery of lamivudine. AAPS Pharm Sci Tech. 2007;8:1-9.
12.    Guo J, Ping Q, Sun G, and Jiao C. Lecithin vesicular carriers for transdermal delivery of cyclosporine A. Int J Pharm. 2000;194(2):201-207
13.    Cevc G, Schatzlein A and Blume G. Transdermal drug carriers: Basic properties, optimization and transfer efficiency in case of epicutaneously applied peptides. J. Control Release.1995;36:3-16
14.    New RRC. Preparation of liposomes and size determination, In: Liposomes A Practical Approach, New RRC (Ed.), Oxford University Press, Oxford, 1990:36-39.
15.     Parashar T, Soniya, Sachan R, Singh V, Singh G , Tyagi S, Patel C, Gupta A. Ethosomes: a recent vesicle of transdermal drug delivery system. Int J Res Dev Pharm Life Sci. 2013; 2(2): 285-292.
16.    Rakesh R, Anoop KR. Ethosomes for transdermal and topical drug delivery Int J Pharm Pharm Sci. 2012;  4(3): 17-24.
17.     Maheshwari RG, Tekade RK, Sharma PA, Darwhekar G, Tyagi A, Patel RP,  Jain DK. Ethosomes and ultradeformable liposomes for transdermal delivery of clotrimazole: A comparative assessment. Saudi Pharm J. 2012;20(2):161–170.
18.    Verma P, Pathak K. Nanosized ethanolic vesicles loaded with econazole nitrate for the treatment of deep fungal infections through topical gel formulation. Nanomed.: Nanotechnol Biol Med. 2012;8(4):489–496.  
19.    Bhalaria M. K, Naik S, Misra A. N. Ethosomes: a novel delivery system for antifungal drugs in the treatment of topical fungal diseases. Indian J Exp Biol. 2009; 47(5): 368–375.
20.    Dave V, Bhardwaj N, Gupta N. et al. Herbal ethosomal gel containing luliconazole for productive relevance in the field of biomedicine. 3 Biotech 10, 97 (2020). 
21.    Zhang L, Li X, Zhu S, Zhang T, Maimaiti A, Ding M, Shi S. Dermal Targeting Delivery of Terbinafine Hydrochloride Using Novel Multi-Ethosomes: A New Approach to Fungal Infection Treatment. Coatings. 2020;10(4):304.
22.    Marto J, Vitor C, Guerreiro A, Severino C, Eleutério C, Ascenso A, Simões S. Ethosomes for enhanced skin delivery of griseofulvin. Colloids and Surfaces B: Biointerfaces. 2016;146: 616-623. 
23.    Godin B, Touitou E, Rubinstein E, Athamna A, Athamna M. A new approach for treatment of deep skin infections by an ethosomal antibiotic preparation: an in vivo studyJ. Antimicrob. Chemother. 2005;55(6):989–994.
24.     Khan S, Dubey BK, Pandey GK, Jain A, Dhakar S, Jain PK. Formulation and Evaluation of Ethosomal Gel of Ciprofloxacin for Bacterial Infections. J Adv Res. 2019; 5(2): 21-25.
25.    Sahu SK, Ram A. Evaluation of Linezolid Loaded Ethosomes for Treatment of Deep Skin Infections in Diabetic Model. Research J Pharm and Tech. 2018;11(7):3023-3030.
26.    Fathalla D, Youssef E, Soliman G. M. Liposomal and Ethosomal Gels for the Topical Delivery of Anthralin: Preparation, Comparative Evaluation and Clinical Assessment in Psoriatic Patients. Pharmaceutics. 2020;12(5): 446. 
27.    Chandra A, Aggarwal G, Manchanda S, Narula A. Development of Topical Gel of Methotrexate Incorporated Ethosomes and Salicylic Acid for the Treatment of Psoriasis. Pharm Nanotechnol. 2019;7(5): 362–374. 
28.    Zhang YT, Shen, LN, Wu ZH, Zhao JH, Nianping F. Comparison of ethosomes and liposomes for skin delivery of psoralen for psoriasis therapy. Int J Pharm. 2014;471.
29.    Zhang Y, Xia Q, Li Y, He Z, Li Z, Guo T, Wu Z, Feng N. CD44 Assists the Topical Anti-Psoriatic Efficacy of Curcumin-Loaded Hyaluronan-Modified Ethosomes: A New Strategy for Clustering Drug in Inflammatory Skin. Theranostics. 2019;9(1):48–64. 
30.    Paolino D, Lucania G, Mardente D, Alhaique F, Fresta M. Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers. J Control Release. 2005;106(1-2):99–110. 
31.    Choi JH, Cho SH, Yun JJ, Yu YB, Cho CW. Ethosomes and Transfersomes for Topical Delivery of Ginsenoside Rhl from Red Ginseng: Characterization and In Vitro Evaluation. J Nanosci Nanotechnol. 2015;15(8):5660-5662. 
32.     Caddeo C, Sales OD, Valenti D, Saurí AR, Fadda AM, Manconi M. Inhibition of skin inflammation in mice by diclofenac in vesicular carriers: liposomes, ethosomes and PEVs. Int J Pharm. 2013;443(1-2):128-136. 
33.    Shen LN, Zhang YT, Wang Q, Xu L, Feng NP. Enhanced in vitro and in vivo skin deposition of apigenin delivered using ethosomes. Int J Pharm. 2014;460(1-2):280-288. 
34.    Moolakkadath T, Aqil M, Ahad A. Fisetin loaded binary ethosomes for management of skin cancer by dermal application on UV exposed mice. Int J Pharm. 2019;560:78-91.
35.     Peram MR, Jalalpure S, Kumbar V. Factorial design based curcumin ethosomal nanocarriers for the skin cancer delivery: in vitro evaluation. J Liposome Res. 2019;29(3):291-311. 
36.    Yu Z, Lv H, Han G, Ma K. Ethosomes Loaded with Cryptotanshinone for Acne Treatment through Topical Gel Formulation. PLoS One. 2016;11(7).
37.    Nakka SR, Hui M S, Chong FP, Foo Y C, Rajabalaya R. Formulation and in vitro evaluation of ethosomes as vesicular carrier for enhanced topical delivery of isotretinoin. Int J Drug Deliv. 2013;5:28-34.
38.    Manosrai A, Jantrawut P, Khositsuntiwong N, Manosroi W, Manosroi J. Novel Elastic Nanovesicles for Cosmeceutical and Pharmaceutical Applications. Chiang Mai J Sci. 2009;36:168–178.
39.    Koli JR, Lin S. Development of anti oxidant ethosomes for topical delivery utilizing the synergistic properties of Vit A palmitate, Vit E and Vit C. AAPS Pharm Sci Tec. 2009;11:1–8.
40.    Esposito E, Menegatti E, Cortesi R. Ethosomes and liposomes as topical vehicles for azelaic acid: a preformulation study. J Cosmet Sci. 2004;55(3):253-264.
41.    Prasanthi D, Lakshmi PK. Development of ethosomes with taguchi robust design-based studies for transdermal delivery of alfuzosin hydrochloride. Int Curr Pharm J. 2012; 1(11):370-375.
42.    Girhepunje K, Pal R, Gevariya H, Behera A, N T. Ethosomes: A Novel Vesicular Carrier for Enhanced Dermal Delivery of Ciclopirox Olamine. Der Pharmacia Lettre 2010; 2(1):360-367.
43.    Paolinoa D, Lucaniab G, Mardentea D, Alhaiquec F, Frestaa M. Ethosomes for skin delivery of ammonium glycyrrhizinate: In vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers. J Control Release. 2005; 106(1-2):99–110.
44.    Saratchandarn C, Shirwaikar A, Sarala Devi A, Vipin KV. Comparative Evaluation of Sonicated and Un-Sonicated Ethosomes Containing Ketoconazole. Int J Adv Pharm Biol Chem. 2012;1(1):15-20.
45.    Shirwaikar A, Kuriakose MR, Sabna NS. Development and evaluation of ethosomes for transdermal delivery of Fluconazole. J Chem Biol Phys Sci. 2012;2(1):254-260.
Nanomedicine Journal
Volume 9, Issue 4
October 2022
Pages 273-280

Files

Share

How to cite

Statistics